Valuation (79%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 5.32 | 42.40 |
PEG Ratio (TTM) | -0.27 | -8.15 |
P/S Ratio (TTM) | 1.46 | 6.64 |
P/B Ratio (TTM) | 2.13 | 10.40 |
P/FCF Ratio (TTM) | 5.22 | 34.88 |
Price to 5YR AVG Earnings Ratio | 0.01 | 60.05 |
Price to 5YR AVG FCF Ratio | 0.00 | 45.38 |
Profitability (90%) |
Company | Industry |
---|---|---|
ROA (TTM) | 21.87% | 13.09% |
ROE (TTM) | 43.51% | 22.79% |
Net Profit Margin (TTM) | 28.76% | 17.89% |
ROIC 5YR AVG | 25.66% | 14.33% |
Growth (47%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -19.71% | -77.03% | 317.09% |
Revenue | -8.24% | 10.99% | 23.51% |
Net Income | -18.70% | -143.82% | 283.85% |
Cash Flow | -4.51% | 97.70% | 50.22% |
Health (77%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.78 | 1.31 |
Quick Ratio (TTM) | 2.67 | 1.05 |
D/E Ratio (TTM) | 0.53 | 0.76 |
Interest Coverage (TTM) | 9.77 | 12.91 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 2.11 | 7.14 |
LTL to 5YR AVG FCF | 1.27 | 6.61 |
Shares Outstanding Growth 5YR AVG | 27.94% | 19.44% |